References
Van Hagen P, Hulshof MC, Van Lanschot JJ, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. Engl J Med. 2012;366:2074–84.
Orringer MD, Forastriere AA, Perez-Tamayo C, et al. Chemotherapy and radiation therapy before transhiatal esophagrectomy for esophageal carcinoma. Ann Thorac Surg. 1990;49(3):348–55.
Goodman KA, Niedzwiecki D, Hall N, et al. Initial results of CALGB 80803 (Alliance): a randomized phase II trial of PET scan-directed combined modality therapy for esophageal cancer. J Clin Oncol. 2017;35(4 Suppl):1.
Worrell SG, Towe CW, Dorth JA, et al. Higher doses of neoadjuvant radiation for esophageal cancer do not affect the pathologic complete response rate or survival: a propensity-matched analysis. Ann Surg Oncol. Epub 30 Sep 2019. https://doi.org/10.1245/s10434-019-07849-z.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
Stephanie G. Worrell and Philip A. Linden report no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
ASO Author Reflections is a brief invited commentary on the article “Higher Doses of Neoadjuvant Radiation for Esophageal Cancer Do Not Affect the Pathologic Complete Response Rate or Survival: A Propensity-Matched Analysis,” Ann Surg Oncol. Epub 30 Sep 2019. https://doi.org/10.1245/s10434-019-07849-z.
Rights and permissions
About this article
Cite this article
Worrell, S.G., Linden, P.A. ASO Author Reflections: More May Not Be Better. Ann Surg Oncol 27, 509–510 (2020). https://doi.org/10.1245/s10434-019-08021-3
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-019-08021-3